Dr. Agarwal's Health Care logo

Dr. Agarwal's Health Care financials: balance sheet, profit and loss, cash flow

NSE: AGARWALEYEBSE: 544350Healthcare ServicesSmall Cap

Dr. Agarwal's Health Care Limited · Face value ₹1 · Listed Feb 2025 · Issue price ₹402
Last close ₹475.15down ₹1.45 (0.30%)BSE ₹472.90

Share price at the NSE close on 28 Oct 2026. Previous close ₹476.60.

28 Oct: open ₹474.85, high ₹478.40, low ₹470.40

52-week range of traded prices to 28 Oct 2026
₹401.00Low, 30 Mar 2026₹567.75High, 11 Aug 2026
Market cap
₹15,063 Cr442nd largest listed
P/E
101.53
P/B
7.44
Dividend yield
Nonein the last 12 months
ROE
7.6%
ROCE
14.1%
Debt to equity
0.07
Volume, NSE
67,39866.4% delivered

Dr. Agarwal's Health Care's financial statements for the 2 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them.

2 years at a glance

₹ crore, years to March.Dr. Agarwal's Health Care annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
1,711110247Mar 252,080168157Mar 26
Peak revenue ₹2,080 Cr, year to Mar 2026; lowest ₹1,711 Cr, year to Mar 2025

Operating and net margin, per cent

  • Operating margin
  • Net margin
27.4%6.4%26.7%27.4%6.4%8.1%Mar 25Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue2,080
  2. Materials and goods−193
  3. Employee costs−404
  4. Other expenses−914
  5. Operating profit570
  6. Depreciation−276
  7. Other income+44
  8. One-off items+1.3
  9. Finance costs−90
  10. Profit before tax249
  11. Tax−81
  12. Net profit168

What the company owns

  • Plant, investments and other assets₹3,405 Cr
  • Receivables₹161 Cr
  • Current investments₹152 Cr
  • Cash and bank₹129 Cr
  • Inventory₹94 Cr

What pays for it: net worth and liabilities

  • Net worth₹2,120 Cr
  • Other liabilities₹1,516 Cr
  • Borrowings₹157 Cr
  • Owed to suppliers₹149 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Dr. Agarwal's Health Care quarterly results

₹ croreMar 2025Mar 2026Filed 21 MayJun 2026Twelve monthsFiled 4 Aug
Revenue from operations1,7112,0802,207
1,2551,5111,595
Materials and goods bought162193204
Employee costs327404429
Other expenses766914961
Operating profit before depreciation456570612
Operating margin26.7%27.4%27.7%
Materials, % of revenue9.5%9.3%9.3%
Employee costs, % of revenue19.1%19.4%19.5%
Other expenses, % of revenue44.7%43.9%43.5%
Depreciation and amortisation231276292
Operating profit after depreciation226293321
Other income464437
Finance costs1099089
Profit before one-off items and tax163247269
One-off items−311
Profit before tax160249270
508185
110168185
Other comprehensive income−11813
Total comprehensive income110186198
Net margin6.4%8.1%8.4%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2025Mar 2026Filed 21 May
1,9272,120
1,8672,025
Share capital3232
Reserves1,8351,994
Belonging to outside owners of subsidiaries6094
247157
478461
1,2671,361
Total assets3,6723,942
2,8783,369
794573
Net debt−275−124
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2025Mar 2026Filed 21 May
360519
397575
−94−48
Receivables−44−54
Inventories−26−14
Payables270
Other working capital−5120
Tax paid−37−55
Capital spending309448
Free cash flow5271
−750−308
382−220
Dividends paid11
Shares bought back00
Shares issued65511
Net change in cash−8−10
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2025Mar 2026Filed 21 May
Earnings per share₹2.80₹4.21
Diluted earnings per share₹2.78₹4.18
Book value per share₹59.09₹63.94
Shareholder yield−4.6%−0.1%
Market cap at the year end (₹ crore)14,08412,866

Ratios

Consolidated, years to March.Dr. Agarwal's Health Care PE ratio and valuation

RatioMar 2025Mar 2026Filed 21 May
Revenue growth–21.6%
Operating profit growth–24.8%
Net profit growth–52.4%
Earnings per share growth–50.4%
4.5%6.8%
–2.4 pts
From the net margin–1.4 pts
From asset turnover–1.0 pts
From borrowing–0.0 pts
Return on capital employed10.4%12.9%
Cash conversion326.6%308.7%
Interest cover2.13.2
Debt to equity0.130.07
Receivable days2628
Inventory days181178
Payable days345283
Cash conversion cycle, days−138−76
Working capital days−25−26
Asset turnover0.470.55
Assets per rupee of net worth1.971.96
Sales per rupee of plant2.422.25
Capital spending to depreciation1.341.62
Plant being built, % of plant in use20.3%25.3%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
3.5%
Cash from operations against operating profit
91.1%
Measure3 years
Return on equity, average5.7%
Return on capital employed, average11.6%
Operating margin, average27.0%
Net margin, average7.3%
Asset turnover, average0.51
Cash conversion cycle, days, average−107
Interest cover, average2.7
Debt to equity, average0.10

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations519
Cash from investing−308
Cash from financing−220
Capital spending448
Dividends paid1
Shares bought back0
Shares issued for cash11
Borrowings raised0
Borrowings repaid90

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2025Mar 2026
Altman Z-scorePublished threshold 1.816.355.79
Beneish M-scorePublished threshold −1.78–−2.54
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–−1.11
Receivables growth less revenue growthOur threshold 0 percentage points–8.66
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−1.79
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−1.53
Assets under construction, years of additionsOur threshold 2 years of additions–0.47
Effective tax ratePublished threshold 17.16 per cent30.9732.38
Tax charged less tax paid, % of profitOur threshold 10 percentage points8.0810.23
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
15 Jun 2026CRISIL Ratings LimitedBank FacilitiesWithdrawnReview, Other50
23 Feb 2026ICRA LimitedFund-based-Term loan[ICRA]AA-Review, Re-affirmStable73.80
23 Feb 2026ICRA LimitedUnallocated limits-Unallocated limits[ICRA]AA- /[ICRA]A1+Review, Re-affirmStable126.20
14 Oct 2025ICRA LimitedUnallocated-UnallocatedLong and short-term scales[ICRA]AA- /[ICRA]A1+New, NewStable11.68
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.